{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:15:02Z","timestamp":1789992902150,"version":"4.0.1"},"reference-count":353,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2024.194","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:20:57Z","timestamp":1726730457000},"source":"Crossref","is-referenced-by-count":17,"title":["Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review)"],"prefix":"10.3892","volume":"4","author":[{"given":"Ibrahim","family":"Khalil","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria 5372066, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Sayad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Assiut University, Assiut 71515, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kedwany","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Assiut University, Assiut 71515, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hager","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Assuit University, Assuit 71515, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Let\u00edcia","family":"Caprara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cooper University Hospital, Camden, NJ 08103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamir","family":"Rissardo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cooper University Hospital, Camden, NJ 08103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"key20241101100449_b1-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson's disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov Disord"},{"key":"key20241101100449_b2-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"key20241101100449_b3-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"key":"key20241101100449_b4-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson's disease: The dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neurodegener Dis"},{"key":"key20241101100449_b5-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ana.10078","article-title":"Dopaminergic modulation of cortical function in patients with Parkinson's disease","volume":"51","author":"Mattay","year":"2002","journal-title":"Ann Neurol"},{"key":"key20241101100449_b6-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/1531-8257(200003)15:2<212::aid-mds1002>3.0.co;2-6","article-title":"Waking up to sleep episodes in Parkinson's disease","volume":"15","author":"Olanow","year":"2000","journal-title":"Mov Disord"},{"key":"key20241101100449_b7-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1532-5415.2012.03966.x","article-title":"Nocturnal hypokinesia and sleep quality in Parkinson's disease","volume":"60","author":"Louter","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"key20241101100449_b8-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic Dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"761044","key":"key20241101100449_b9-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.761044","article-title":"Characteristics of Autonomic Dysfunction in Parkinson's disease: A large chinese multicenter cohort study","volume":"13","author":"Zhou","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"key20241101100449_b10-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2007.10.016","article-title":"Urinary dysfunction in Parkinson's disease: A review","volume":"15","author":"Blackett","year":"2009","journal-title":"Park Relat Disord"},{"key":"key20241101100449_b11-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.nbd.2011.10.002","article-title":"Pathophysiology of bladder dysfunction in Parkinson's disease","volume":"46","author":"Sakakibara","year":"2012","journal-title":"Neurobiol Dis"},{"key":"key20241101100449_b12-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","article-title":"Bladder and bowel dysfunction in Parkinson's disease","volume":"115","author":"Sakakibara","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"key":"key20241101100449_b13-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0022-510x(01)00521-4","article-title":"SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction","volume":"187","author":"Sakakibara","year":"2001","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b14-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1468-1331.2005.01087.x","article-title":"Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease","volume":"12","author":"Winge","year":"2005","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b15-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol"},{"key":"key20241101100449_b16-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/wnl.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson's disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"key20241101100449_b17-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"key20241101100449_b18-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson's disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b19-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1468-1331.2012.03819.x","article-title":"The potential prognostic role of cardiovascular autonomic failure in \u03b1-synucleinopathies","volume":"20","author":"Fanciulli","year":"2013","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b20-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/wnl.26.5.423","article-title":"Primary sensory symptoms in parkinsonism","volume":"26","author":"Snider","year":"1976","journal-title":"Neurology"},{"key":"key20241101100449_b21-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.870010106","article-title":"Pain in Parkinson's disease","volume":"1","author":"Goetz","year":"1986","journal-title":"Mov Disord"},{"key":"key20241101100449_b22-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3810\/pgm.2001.12.1063","article-title":"Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable","volume":"110","author":"Waseem","year":"2001","journal-title":"Postgrad Med"},{"key":"key20241101100449_b23-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1460-9568.2006.04942.x","article-title":"Multisensory integration in the basal ganglia","volume":"24","author":"Nagy","year":"2006","journal-title":"Eur J Neurosci"},{"key":"key20241101100449_b24-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0079-6123(03)43023-9","article-title":"Role of basal ganglia-brainstem systems in the control of postural muscle tone and locomotion","volume":"143","author":"Takakusaki","year":"2004","journal-title":"Prog Brain Res"},{"key":"key20241101100449_b25-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/WCO.0000000000000384","article-title":"Clinical subtypes and genetic heterogeneity: Of lumping and splitting in Parkinson disease","volume":"29","author":"von Coelln","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"key20241101100449_b26-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"issue":"104700","key":"key20241101100449_b27-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol Dis"},{"key":"key20241101100449_b28-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-m","article-title":"Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"Am J Med"},{"key":"key20241101100449_b29-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol"},{"key":"key20241101100449_b30-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/aomd.aomd_52_22","article-title":"Risk factors for Parkinson's disease dementia","volume":"6","author":"Rissardo","year":"2023","journal-title":"Ann Mov Disord"},{"key":"key20241101100449_b31-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/jnnp-2016-314123","article-title":"Under pressure. Is There a Link between Orthostatic hypotension and cognitive impairment in \u03b1-Synucleinopathies","volume":"87","author":"Udow","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b32-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","article-title":"EFNS guidelines on the diagnosis and management of Orthostatic hypotension","volume":"13","author":"Lahrmann","year":"2006","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b33-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of Orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b34-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00702-015-1396-2","article-title":"Falls in ambulatory non-demented patients with Parkinson's disease","volume":"122","author":"Rascol","year":"2015","journal-title":"J Neural Transm(Vienna)"},{"key":"key20241101100449_b35-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/jnnp.2006.112367","article-title":"Cognitive impairment in Parkinson's disease","volume":"78","author":"Verbaan","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b36-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","article-title":"Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients","volume":"22","author":"Martinez-Martin","year":"2007","journal-title":"Mov Disord"},{"key":"key20241101100449_b37-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40120-019-00152-9","article-title":"Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer","volume":"8","author":"Cutsforth-Gregory","year":"2019","journal-title":"Neurol Ther"},{"key":"key20241101100449_b38-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/AOMD.AOMD_33_19","article-title":"Parkinson's disease rating scales: A literature review","volume":"3","author":"Pitton Rissardo","year":"2020","journal-title":"Ann Mov Disord"},{"key":"key20241101100449_b39-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/01.HYP.0000081216.11623.C3","article-title":"Association between supine hypertension and Orthostatic Hypotension in autonomic failure","volume":"42","author":"Goldstein","year":"2003","journal-title":"Hypertension"},{"key":"key20241101100449_b40-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"key":"key20241101100449_b41-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","article-title":"Renal impairment of pure autonomic failure","volume":"54","author":"Garland","year":"2009","journal-title":"Hypertension"},{"key":"key20241101100449_b42-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41371-019-0193-z","article-title":"Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: A post hoc analysis of the HeadPoST study","volume":"33","author":"Minhas","year":"2019","journal-title":"J Hum Hypertens"},{"key":"key20241101100449_b43-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.CIR.0000154900.76284.F6","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood pressure Research","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"key":"key20241101100449_b44-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/08037050701461084","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"key20241101100449_b45-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertens Res"},{"key":"key20241101100449_b46-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/01.HYP.0000258215.26755.20","article-title":"Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation","volume":"49","author":"Verdecchia","year":"2007","journal-title":"Hypertension"},{"key":"key20241101100449_b47-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/hjh.0b013e32834192d5","article-title":"Subjective sleep disturbance increases the nocturnal blood pressure level and attenuates the correlation with target-organ damage","volume":"29","author":"Henskens","year":"2011","journal-title":"J Hypertens"},{"key":"key20241101100449_b48-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension","volume":"348","author":"Clement","year":"2003","journal-title":"N Engl J Med"},{"key":"key20241101100449_b49-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertension"},{"key":"key20241101100449_b50-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000160923.04524.5B","article-title":"Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study","volume":"111","author":"Sega","year":"2005","journal-title":"Circulation"},{"key":"key20241101100449_b51-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.107.087262","article-title":"Predictors of all-cause mortality in clinical ambulatory monitoring: Unique aspects of blood pressure during sleep","volume":"49","author":"Ben-Dov","year":"2007","journal-title":"Hypertension"},{"key":"key20241101100449_b52-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(07)61538-4","article-title":"Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study","volume":"370","author":"Boggia","year":"2007","journal-title":"Lancet"},{"issue":"397","key":"key20241101100449_b53-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)92867-x","article-title":"Dippers and non-dippers","volume":"2","author":"O'Brien","year":"1988","journal-title":"Lancet"},{"key":"key20241101100449_b54-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.cir.81.2.528","article-title":"Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension","volume":"81","author":"Verdecchia","year":"1990","journal-title":"Circulation"},{"key":"key20241101100449_b55-MI-4-6-00194","first-page":"875","article-title":"Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension","volume":"10","author":"Shimada","year":"1992","journal-title":"J Hypertens"},{"key":"key20241101100449_b56-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.hyp.27.1.130","article-title":"Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers","volume":"27","author":"Kario","year":"1996","journal-title":"Hypertension"},{"key":"key20241101100449_b57-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.parkreldis.2014.02.007","article-title":"Postprandial hypotension in de novo Parkinson's disease: A comparison with orthostatic hypotension","volume":"20","author":"Umehara","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b58-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"286","DOI":"10.7326\/0003-4819-122-4-199502150-00009","article-title":"Postprandial hypotension: Epidemiology, pathophysiology, and clinical management","volume":"122","author":"Jansen","year":"1995","journal-title":"Ann Intern Med"},{"key":"key20241101100449_b59-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/wnl.43.5.900","article-title":"Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease multiple system atrophy, and pure autonomic failure","volume":"43","author":"Thomaides","year":"1993","journal-title":"Neurology"},{"issue":"e35411","key":"key20241101100449_b60-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35411","article-title":"Postprandial Hypotension: An underreported silent killer in the aged","volume":"15","author":"Awosika","year":"2023","journal-title":"Cureus"},{"key":"key20241101100449_b61-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.autneu.2012.07.008","article-title":"Exercise-induced hypotension in autonomic disorders","volume":"171","author":"Low","year":"2012","journal-title":"Auton Neurosci"},{"key":"key20241101100449_b62-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0002-8703(71)90099-8","article-title":"Cardiovascular observations on Tarahumara Indian runners-the modern Spartans","volume":"81","author":"Groom","year":"1971","journal-title":"Am Heart J"},{"key":"key20241101100449_b63-MI-4-6-00194","first-page":"251","article-title":"Postural hypotension enhanced by exercise in patients with chronic autonomic failure","volume":"88","author":"Smith","year":"1995","journal-title":"QJM"},{"key":"key20241101100449_b64-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.hyp.22.5.653","article-title":"Postexercise hypotension. Key features, mechanisms, and clinical significance","volume":"22","author":"Kenney","year":"1993","journal-title":"Hypertension"},{"key":"key20241101100449_b65-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1519\/JSC.0b013e3181bb71aa","article-title":"The effects of muscle mass and number of sets during resistance exercise on postexercise hypotension","volume":"23","author":"Polito","year":"2009","journal-title":"J Strength Cond Res"},{"key":"key20241101100449_b66-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2231-0770.127415","article-title":"Avicenna's contribution to cardiology","volume":"4","author":"Chamsi-Pasha","year":"2014","journal-title":"Avicenna J Med"},{"key":"key20241101100449_b67-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1001\/jama.2011.1826","article-title":"Temporal changes in resting heart rate and deaths from ischemic heart disease","volume":"306","author":"Nauman","year":"2011","journal-title":"JAMA"},{"key":"key20241101100449_b68-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJM199910283411804","article-title":"Heart-rate recovery immediately after exercise as a predictor of mortality","volume":"341","author":"Cole","year":"1999","journal-title":"N Engl J Med"},{"key":"key20241101100449_b69-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1172\/JCI107731","article-title":"Autonomic mechanisms in hemodynamic responses to isometric exercise","volume":"54","author":"Martin","year":"1974","journal-title":"J Clin Invest"},{"key":"key20241101100449_b70-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"H1763","DOI":"10.1152\/ajpheart.00785.2004","article-title":"Heart rate recovery after exercise: A predictor of ventricular fibrillation susceptibility after myocardial infarction","volume":"288","author":"Smith","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20241101100449_b71-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1161\/CIRCULATIONAHA.104.497347","article-title":"Does autonomic function link social position to coronary risk? The Whitehall II study","volume":"111","author":"Hemingway","year":"2005","journal-title":"Circulation"},{"key":"key20241101100449_b72-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.cir.0000047275.25795.17","article-title":"Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients","volume":"107","author":"La Rovere","year":"2003","journal-title":"Circulation"},{"key":"key20241101100449_b73-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S1474-4422(09)70291-1","article-title":"Progression of Parkinson's disease in the clinical phase: Potential markers","volume":"8","author":"Maetzler","year":"2009","journal-title":"Lancet Neurol"},{"issue":"339","key":"key20241101100449_b74-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02872-2","article-title":"Power spectral analysis of heart rate variability is useful as a screening tool for detecting sympathetic and parasympathetic nervous dysfunctions in Parkinson's disease","volume":"22","author":"Miyagi","year":"2022","journal-title":"BMC Neurol"},{"key":"key20241101100449_b75-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"BC01","DOI":"10.7860\/JCDR\/2014\/9470.4550","article-title":"Influence of deep breathing on heart rate variability in Parkinson's disease: Co-relation with severity of disease and non-motor symptom scale score","volume":"8","author":"Bidikar","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"025002","key":"key20241101100449_b76-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.7.2.025002","article-title":"Cerebral hemodynamic monitoring of Parkinson's disease patients with orthostatic intolerance during head-up tilt test","volume":"7","author":"Kim","year":"2020","journal-title":"Neurophotonics"},{"key":"key20241101100449_b77-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00702-009-0239-4","article-title":"Valsalva manoeuvre in patients with different Parkinsonian disorders","volume":"116","author":"Schmidt","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"issue":"833344","key":"key20241101100449_b78-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.833344","article-title":"Effectiveness of different methods for baroreflex sensitivity assessment in determining the severity of cardiovascular autonomic neuropathy in patients With Parkinson's disease","volume":"16","author":"Huang","year":"2022","journal-title":"Front Neurosci"},{"key":"key20241101100449_b79-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"M535","DOI":"10.1093\/gerona\/55.9.m535","article-title":"Ambulatory blood pressure monitoring and postprandial hypotension in elderly persons with falls or syncopes","volume":"55","author":"Puisieux","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"e2428","key":"key20241101100449_b80-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2428","article-title":"24-hour ambulatory blood pressure alterations in patients with Parkinson's disease","volume":"12","author":"Shen","year":"2022","journal-title":"Brain Behav"},{"key":"key20241101100449_b81-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/mds.22612","article-title":"Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication","volume":"24","author":"DiFrancisco-Donoghue","year":"2009","journal-title":"Mov Disord"},{"key":"key20241101100449_b82-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1002\/clc.4960181304","article-title":"Plasma norepinephrine and mortality","volume":"18 (3 Suppl I)","author":"Cohn","year":"1995","journal-title":"Clin Cardiol"},{"key":"key20241101100449_b83-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.cir.101.5.558","article-title":"Beta-adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"key20241101100449_b84-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1152\/jappl.1989.66.4.1736","article-title":"Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans","volume":"66","author":"Rowell","year":"1989","journal-title":"J Appl Physiol (1985)"},{"key":"key20241101100449_b85-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/WNL.0b013e3181aae83c","article-title":"Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease","volume":"73","author":"Akaogi","year":"2009","journal-title":"Neurology"},{"key":"key20241101100449_b86-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neulet.2007.01.033","article-title":"The raphe magnus\/pallidus regulates sweat secretion and skin vasodilation of the cat forepaw pad: A preliminary electrical stimulation study","volume":"415","author":"Asahina","year":"2007","journal-title":"Neurosci Lett"},{"key":"key20241101100449_b87-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.parkreldis.2015.05.006","article-title":"Abnormal thermography in Parkinson's disease","volume":"21","author":"Antonio-Rubio","year":"2015","journal-title":"Park Relat Disord"},{"key":"key20241101100449_b88-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1471","key":"key20241101100449_b89-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13101471","article-title":"Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's disease: A comprehensive review","volume":"13","author":"Pitton Rissardo","year":"2023","journal-title":"Brain Sci"},{"key":"key20241101100449_b90-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/mds.10461","article-title":"Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease","volume":"18","author":"Courbon","year":"2003","journal-title":"Mov Disord"},{"key":"key20241101100449_b91-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2016.01.020","article-title":"Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder","volume":"362","author":"Kim","year":"2016","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b92-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","article-title":"Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease","volume":"19","author":"Yoshita","year":"1998","journal-title":"Nucl Med Commun"},{"key":"key20241101100449_b93-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"Amino","year":"2005","journal-title":"Brain Pathol"},{"key":"key20241101100449_b94-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1212\/wnl.57.6.1140","article-title":"Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA","volume":"57","author":"Orimo","year":"2001","journal-title":"Neurology"},{"key":"key20241101100449_b95-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1001\/archneur.60.10.1400","article-title":"Orthostatic hypotension in de novo Parkinson disease","volume":"60","author":"Bonuccelli","year":"2003","journal-title":"Arch Neurol"},{"key":"key20241101100449_b96-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejim.2006.02.020","article-title":"Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson's disease","volume":"17","author":"Ejaz","year":"2006","journal-title":"Eur J Intern Med"},{"key":"key20241101100449_b97-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","article-title":"Autonomic dysfunction in Parkinson disease","volume":"117","author":"Kaufmann","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"key20241101100449_b98-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000002030","article-title":"Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study","volume":"85","author":"Gibbons","year":"2015","journal-title":"Neurology"},{"key":"key20241101100449_b99-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/mds.22537","article-title":"Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?","volume":"24","author":"Jamnadas-Khoda","year":"2009","journal-title":"Mov Disord"},{"key":"key20241101100449_b100-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"key20241101100449_b101-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/mds.27268","article-title":"Autonomic dysfunction in Parkinson's disease: A prospective cohort study","volume":"33","author":"Merola","year":"2018","journal-title":"Mov Disord"},{"issue":"897","key":"key20241101100449_b102-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00897","article-title":"Orthostatic hypotension is associated with cognitive decline in Parkinson disease","volume":"11","author":"Longardner","year":"2020","journal-title":"Front Neurol"},{"key":"key20241101100449_b103-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.26632","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"Mov Disord"},{"key":"key20241101100449_b104-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov Disord"},{"key":"key20241101100449_b105-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JPD-160925","article-title":"Dementia Predictors in Parkinson Disease: A validation study","volume":"7","author":"Anang","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"key20241101100449_b106-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2019.10.023","article-title":"Cardiovascular autonomic function and MCI in Parkinson's disease","volume":"69","author":"Cicero","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b107-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/WNL.0000000000003452","article-title":"Effects of Orthostatic hypotension on cognition in Parkinson disease","volume":"88","author":"Centi","year":"2017","journal-title":"Neurology"},{"key":"key20241101100449_b108-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10072-018-3394-2","article-title":"Orthostatic hypotension acutely impairs executive functions in Parkinson's disease","volume":"39","author":"Sforza","year":"2018","journal-title":"Neurol Sci"},{"key":"key20241101100449_b109-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00702-006-0615-2","article-title":"Orthostatic hypotension and attention in Parkinson's disease with and without dementia","volume":"114","author":"Peralta","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"key20241101100449_b110-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","article-title":"Supine hypertension in Parkinson's disease and multiple system atrophy","volume":"26","author":"Fanciulli","year":"2016","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b111-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1524-6175.2001.00516.x","article-title":"Diagnosis and treatment of Supine hypertension in autonomic failure patients with orthostatic hypotension","volume":"4","author":"Jordan","year":"2002","journal-title":"J Clin Hypertens Greenwich"},{"key":"key20241101100449_b112-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key20241101100449_b113-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.0b013e31826c1acd","article-title":"Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease","volume":"79","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"key20241101100449_b114-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/mds.22767","article-title":"Loss of nocturnal blood pressure fall in various extrapyramidal syndromes","volume":"24","author":"Schmidt","year":"2009","journal-title":"Mov Disord"},{"issue":"897586","key":"key20241101100449_b115-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/897586","article-title":"Nondipping in blood pressure","volume":"2011","author":"Sommer","year":"2011","journal-title":"Park Dis"},{"key":"key20241101100449_b116-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","article-title":"Consensus statement on the definition of neurogenic SH in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b117-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of Supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b118-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.parkreldis.2020.04.011","article-title":"The impact of Supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension","volume":"75","author":"Palma","year":"2020","journal-title":"Park Relat Disord"},{"key":"key20241101100449_b119-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2017.10.014","article-title":"Association between abnormal nocturnal blood pressure profile and dementia in Parkinson's disease","volume":"46","author":"Tanaka","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b120-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/07420528.2013.766618","article-title":"Nighttime blood pressure and white matter hyperintensities in patients with Parkinson disease","volume":"30","author":"Oh","year":"2013","journal-title":"Chronobiol Int"},{"key":"key20241101100449_b121-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ene.12412","article-title":"The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease","volume":"21","author":"Sunwoo","year":"2014","journal-title":"Eur J Neurol"},{"issue":"350","key":"key20241101100449_b122-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01928-5","article-title":"Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies","volume":"20","author":"Oka","year":"2020","journal-title":"BMC Neurol"},{"key":"key20241101100449_b123-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27135","article-title":"Cognitive changes in prodromal Parkinson's disease: A review","volume":"32","author":"Fengler","year":"2017","journal-title":"Mov Disord"},{"key":"key20241101100449_b124-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jalz.2011.09.230","article-title":"Risk of dementia in an elderly population of Parkinson's disease patients: A 15-year population-based study","volume":"8","author":"Perez","year":"2012","journal-title":"Alzheimers Dement"},{"key":"key20241101100449_b125-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/wnl.56.6.730","article-title":"Risk of dementia in Parkinson's disease: A community-based, prospective study","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology"},{"key":"key20241101100449_b126-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov Disord"},{"key":"key20241101100449_b127-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"key20241101100449_b128-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"key20241101100449_b129-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"key":"key20241101100449_b130-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/jnnp-2016-315099","article-title":"Stability of mild cognitive impairment in newly diagnosed Parkinson's disease","volume":"88","author":"Lawson","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b131-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ane.12375","article-title":"Cognitive function in the early phase of Parkinson's disease, a five-year follow-up","volume":"132","author":"Domellof","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"key20241101100449_b132-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"key":"key20241101100449_b133-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","article-title":"Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study","volume":"88","author":"Pedersen","year":"2017","journal-title":"Neurology"},{"key":"key20241101100449_b134-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2017.12.006","article-title":"Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort","volume":"47","author":"Jones","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b135-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0891988714532015","article-title":"Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?","volume":"27","author":"Erro","year":"2014","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"key20241101100449_b136-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/mds.28115","article-title":"Subjective Cognitive Complaint in Parkinson's disease patients with normal cognition: Canary in the coal mine?","volume":"35","author":"Purri","year":"2020","journal-title":"Mov Disord"},{"key":"key20241101100449_b137-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2020.11.013","article-title":"Subjective cognitive Complaints in early Parkinson's disease patients with normal cognition are associated with affective symptoms","volume":"82","author":"Chua","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b138-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2013.09.025","article-title":"The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort","volume":"20","author":"Szewczyk-Krolikowski","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"e0133002","key":"key20241101100449_b139-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133002","article-title":"Sex differences in clinical features of early, treated Parkinson's disease","volume":"10","author":"Augustine","year":"2015","journal-title":"PLoS One"},{"key":"key20241101100449_b140-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jocn.2014.08.032","article-title":"Sex differences in cognition among Chinese people with Parkinson's disease","volume":"22","author":"Gao","year":"2015","journal-title":"J Clin Neurosci"},{"key":"key20241101100449_b141-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1212\/WNL.0000000000001609","article-title":"Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"key20241101100449_b142-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.0000000000003288","article-title":"Female advantage in verbal memory: Evidence of sex-specific cognitive reserve","volume":"87","author":"Sundermann","year":"2016","journal-title":"Neurology"},{"issue":"74","key":"key20241101100449_b143-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3390\/bs11050074","article-title":"Cognitive Impairment in Parkinson's disease: Epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"key20241101100449_b144-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00415-014-7560-z","article-title":"Correlates of cerebrospinal fluid levels of oligomeric- and total-\u03b1-synuclein in premotor, motor and dementia stages of Parkinson's disease","volume":"262","author":"Compta","year":"2015","journal-title":"J Neurol"},{"key":"key20241101100449_b145-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid \u03b1-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am J Pathol"},{"issue":"25","key":"key20241101100449_b146-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"key20241101100449_b147-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.27867","article-title":"Pathological influences on clinical heterogeneity in lewy body diseases","volume":"35","author":"Coughlin","year":"2020","journal-title":"Mov Disord"},{"key":"key20241101100449_b148-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"key20241101100449_b149-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","article-title":"Neuropathology of dementia in patients with Parkinson's disease: A systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b150-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000094871","article-title":"Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia","volume":"22","author":"Mollenhauer","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key20241101100449_b151-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b152-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional multiple pathology scores are associated with cognitive decline in lewy body dementias","volume":"25","author":"Howlett","year":"2015","journal-title":"Brain Pathol"},{"key":"key20241101100449_b153-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00702-007-0856-8","article-title":"Cerebral amyloid angiopathy in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"key":"key20241101100449_b154-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","article-title":"Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia","volume":"47","author":"Hansen","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key20241101100449_b155-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2016.03.006","article-title":"Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder","volume":"27","author":"Chahine","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b156-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mdc3.13143","article-title":"Modifiable comorbidities associated with cognitive decline in Parkinson's disease","volume":"8","author":"Forbes","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"key20241101100449_b157-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/mds.27665","article-title":"Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies","volume":"34","author":"Guo","year":"2019","journal-title":"Mov Disord"},{"key":"key20241101100449_b158-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","article-title":"Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study","volume":"5","author":"Kivipelto","year":"2006","journal-title":"Lancet Neurol"},{"key":"key20241101100449_b159-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ene.13797","article-title":"Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease","volume":"26","author":"Chahine","year":"2019","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b160-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1212\/WNL.0000000000001716","article-title":"Cognitive correlates of white matter lesion load and brain atrophy: The Northern Manhattan Study","volume":"85","author":"Dong","year":"2015","journal-title":"Neurology"},{"key":"key20241101100449_b161-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1212\/WNL.0b013e3182a43e45","article-title":"Neuropathologic basis of white matter hyperintensity accumulation with advanced age","volume":"81","author":"Erten-Lyons","year":"2013","journal-title":"Neurology"},{"key":"key20241101100449_b162-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","article-title":"Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov Disord"},{"key":"key20241101100449_b163-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.archger.2011.06.022","article-title":"Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD)","volume":"55","author":"Kim","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"key20241101100449_b164-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3988\/jcn.2019.15.4.517","article-title":"The influence of body mass index at diagnosis on cognitive decline in Parkinson's disease","volume":"15","author":"Yoo","year":"2019","journal-title":"J Clin Neurol"},{"key":"key20241101100449_b165-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: A prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"key":"key20241101100449_b166-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/wnl.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"key":"key20241101100449_b167-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1468-1331.2006.01092.x","article-title":"The effect of ischemic cerebrovascular disease on the clinical characteristics of Parkinson's disease. A post-mortem study","volume":"13","author":"Papapetropoulos","year":"2006","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b168-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-007-0116-y","article-title":"Towards a pathway definition of Parkinson's disease: A complex disorder with links to cancer, diabetes and inflammation","volume":"9","author":"Moran","year":"2008","journal-title":"Neurogenetics"},{"issue":"e18660","key":"key20241101100449_b169-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018660","article-title":"Shared molecular and functional frameworks among five complex human disorders: A comparative study on interactomes linked to susceptibility genes","volume":"6","author":"Menon","year":"2011","journal-title":"PLoS One"},{"key":"key20241101100449_b170-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","article-title":"The association between type 2 diabetes mellitus and Parkinson's disease","volume":"10","author":"Cheong","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"key20241101100449_b171-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","article-title":"Shared dysregulated pathways lead to Parkinson's disease and diabetes","volume":"19","author":"Santiago","year":"2013","journal-title":"Trends Mol Med"},{"key":"key20241101100449_b172-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","article-title":"Dementia is associated with insulin resistance in patients with Parkinson's disease","volume":"315","author":"Bosco","year":"2012","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b173-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/s0317167100012981","article-title":"Serum urate and the risk of Parkinson's disease: Results from a meta-analysis","volume":"40","author":"Shen","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"key20241101100449_b174-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson's disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"key":"key20241101100449_b175-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000327748","article-title":"The risk of Parkinson disease associated with urate in a community-based cohort of older adults","volume":"36","author":"Jain","year":"2011","journal-title":"Neuroepidemiology"},{"key":"key20241101100449_b176-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4103\/mmj.mmj_62_22","article-title":"Uric acid and Parkinson's disease","volume":"35","author":"Rissardo","year":"2023","journal-title":"Menoufia Med J"},{"key":"key20241101100449_b177-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2011-110587","article-title":"Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-\u03b2 pathway","volume":"27","author":"Maetzler","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"key20241101100449_b178-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2007.11.001","article-title":"Uric acid associates with cognition in Parkinson's disease","volume":"14","author":"Annanmaki","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b179-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.parkreldis.2014.03.016","article-title":"Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?","volume":"20","author":"Moccia","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b180-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ene.12533","article-title":"Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's disease","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b181-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog Neurobiol"},{"key":"key20241101100449_b182-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","article-title":"Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia","volume":"11","author":"Fan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"key20241101100449_b183-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson's disease, insulin resistance and novel agents of neuroprotection","volume":"136(Pt 2)","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"key20241101100449_b184-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/FBP.0000000000000505","article-title":"Mitochondrial metabolism: A common link between neuroinflammation and neurodegeneration","volume":"30","author":"Garabadu","year":"2019","journal-title":"Behav Pharmacol"},{"issue":"548283","key":"key20241101100449_b185-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.548283","article-title":"The Role Glial Mitochondria in \u03b1-Synuclein Toxicity","volume":"8","author":"Jeon","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"key20241101100449_b186-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mds.26513","article-title":"Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency","volume":"31","author":"Gatt","year":"2016","journal-title":"Mov Disord"},{"key":"key20241101100449_b187-MI-4-6-00194","author":"Toklu"},{"key":"key20241101100449_b188-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/B978-0-444-63521-1.00030-3","article-title":"Movement disorders secondary to craniocerebral trauma","volume":"128","author":"Krauss","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"key20241101100449_b189-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.05.024","article-title":"Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study","volume":"30","author":"Schiehser","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b190-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD Study","volume":"137(Pt 10)","author":"Nombela","year":"2014","journal-title":"Brain"},{"key":"key20241101100449_b191-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson's disease susceptibility and cognitive symptom progression","volume":"6","author":"Paul","year":"2016","journal-title":"J Park Dis"},{"key":"key20241101100449_b192-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J Neurol"},{"key":"key20241101100449_b193-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b194-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature19766","article-title":"Autocrine BDNF-TrkB signalling within a single dendritic spine","volume":"538","author":"Harward","year":"2016","journal-title":"Nature"},{"key":"key20241101100449_b195-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J Neurosci"},{"key":"key20241101100449_b196-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/j.1468-1331.2009.02706.x","article-title":"BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease","volume":"16","author":"Guerini","year":"2009","journal-title":"Eur J Neurol"},{"key":"key20241101100449_b197-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jocn.2011.03.015","article-title":"Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population","volume":"18","author":"Karakasis","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"e38469","key":"key20241101100449_b198-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038469","article-title":"Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology","volume":"7","author":"The","year":"2012","journal-title":"PLoS One"},{"key":"key20241101100449_b199-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000352033","article-title":"No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease","volume":"70","author":"Svetel","year":"2013","journal-title":"Eur Neurol"},{"issue":"17013","key":"key20241101100449_b200-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Primer"},{"issue":"80","key":"key20241101100449_b201-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-Synuclein Induced Synaptopathy in Parkinson's disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front Neurosci"},{"issue":"47","key":"key20241101100449_b202-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Primer"},{"issue":"47","key":"key20241101100449_b203-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00047","article-title":"Imaging Mild Cognitive Impairment and Dementia in Parkinson's disease","volume":"11","author":"Sasikumar","year":"2020","journal-title":"Front Neurol"},{"key":"key20241101100449_b204-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/1073858415602850","article-title":"Doping the Mind: Dopaminergic modulation of prefrontal cortical cognition","volume":"22","author":"Ranganath","year":"2016","journal-title":"Neuroscientist"},{"key":"key20241101100449_b205-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.aaz5891","article-title":"Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work","volume":"367","author":"Westbrook","year":"2020","journal-title":"Science"},{"key":"key20241101100449_b206-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","article-title":"Histologic validation of locus coeruleus MRI contrast in post-mortem tissue","volume":"113","author":"Keren","year":"2015","journal-title":"Neuroimage"},{"issue":"6031478","key":"key20241101100449_b207-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6031478","article-title":"Noradrenergic modulation of cognition in health and disease","volume":"2017","author":"Borodovitsyna","year":"2017","journal-title":"Neural Plast"},{"key":"key20241101100449_b208-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/brain\/aww006","article-title":"The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder","volume":"139(Pt 4)","author":"Ehrminger","year":"2016","journal-title":"Brain"},{"key":"key20241101100449_b209-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson's disease: An 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"issue":"28","key":"key20241101100449_b210-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-016-0410-9","article-title":"Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders","volume":"18","author":"Sinn","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"key20241101100449_b211-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuroscience.2019.09.036","article-title":"Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability","volume":"422","author":"Zhan","year":"2019","journal-title":"Neuroscience"},{"key":"key20241101100449_b212-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/acn3.246","article-title":"Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease","volume":"2","author":"Buddhala","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"key20241101100449_b213-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/brain\/awz193","article-title":"Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases","volume":"142","author":"Betts","year":"2019","journal-title":"Brain"},{"key":"key20241101100449_b214-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"key":"key20241101100449_b215-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol"},{"issue":"104831","key":"key20241101100449_b216-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104831","article-title":"Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease","volume":"139","author":"Pereira","year":"2020","journal-title":"Neurobiol Dis"},{"key":"key20241101100449_b217-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"issue":"409","key":"key20241101100449_b218-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01102-y","article-title":"Correction: Correlation between cognition and plasma noradrenaline level in Alzheimer's disease: A potential new blood marker of disease evolution","volume":"10","author":"Pillet","year":"2020","journal-title":"Transl Psychiatry"},{"key":"key20241101100449_b219-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/nan.12577","article-title":"Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders","volume":"46","author":"Alexandris","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key20241101100449_b220-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004010100372","article-title":"Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment","volume":"102","author":"Mattila","year":"2001","journal-title":"Acta Neuropathol"},{"key":"key20241101100449_b221-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/(SICI)1096-9861(19961028)374:4<555::AID-CNE6>3.0.CO;2-0","article-title":"Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. Substantia nigra-ventral tegmental area projections to cholinergic neurons","volume":"374","author":"Gaykema","year":"1996","journal-title":"J Comp Neurol"},{"key":"key20241101100449_b222-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mds.27561","article-title":"Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease","volume":"34","author":"Gargouri","year":"2019","journal-title":"Mov Disord"},{"key":"key20241101100449_b223-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease","volume":"137(Pt 9)","author":"Hall","year":"2014","journal-title":"Brain"},{"issue":"61","key":"key20241101100449_b224-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0717-3","article-title":"Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive decline","volume":"7","author":"Liu","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"192","key":"key20241101100449_b225-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01777-2","article-title":"Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort","volume":"20","author":"Nicastro","year":"2020","journal-title":"BMC Neurol"},{"key":"key20241101100449_b226-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138 (Pt 10)","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"key20241101100449_b227-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease","volume":"139 (Pt 9)","author":"Maillet","year":"2016","journal-title":"Brain"},{"key":"key20241101100449_b228-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/ane.13226","article-title":"Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study","volume":"141","author":"Smith","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"267","key":"key20241101100449_b229-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00954-8","article-title":"Neuroinflammation in dementia with Lewy bodies: A human post-mortem study","volume":"10","author":"Amin","year":"2020","journal-title":"Transl Psychiatry"},{"key":"key20241101100449_b230-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","article-title":"Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease","volume":"68","author":"Devanand","year":"2007","journal-title":"Neurology"},{"key":"key20241101100449_b231-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"10919","key":"key20241101100449_b232-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47227-z","article-title":"Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders","volume":"9","author":"Schaser","year":"2019","journal-title":"Sci Rep"},{"key":"key20241101100449_b233-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov Disord"},{"key":"key20241101100449_b234-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/acn3.51195","article-title":"Amyloid-\u03b2 PET and CSF in an autopsy-confirmed cohort","volume":"7","author":"Reimand","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"key20241101100449_b235-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological ?-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology","volume":"131","author":"Toledo","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20241101100449_b236-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","article-title":"Cognitive Profile and Markers of Alzheimer disease-type pathology in patients with lewy body dementias","volume":"96","author":"Howard","year":"2021","journal-title":"Neurology"},{"key":"key20241101100449_b237-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","article-title":"Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's disease","volume":"36","author":"Tan","year":"2021","journal-title":"Mov Disord"},{"key":"key20241101100449_b238-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/mds.28037","article-title":"Rare variants in specific lysosomal genes are associated with Parkinson's disease","volume":"35","author":"Hopfner","year":"2020","journal-title":"Mov Disord"},{"key":"key20241101100449_b239-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/mds.24045","article-title":"Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course","volume":"27","author":"Set\u00f3-Salvia","year":"2012","journal-title":"Mov Disord"},{"key":"key20241101100449_b240-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat Genet"},{"issue":"102","key":"key20241101100449_b241-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00637-x","article-title":"Characterization of a pathogenic variant in GBA for Parkinson's disease with mild cognitive impairment patients","volume":"13","author":"Jiang","year":"2020","journal-title":"Mol Brain"},{"issue":"e0044","key":"key20241101100449_b242-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.446","article-title":"Dopamine pathway gene variants may modulate cognitive performance in the DHS-Mind Study","volume":"6","author":"Martelle","year":"2016","journal-title":"Brain Behav"},{"key":"key20241101100449_b243-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"e2045","DOI":"10.1212\/WNL.0000000000006576","article-title":"Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study","volume":"91","author":"B\u00e4ckstr\u00f6m","year":"2018","journal-title":"Neurology"},{"key":"key20241101100449_b244-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ana.20635","article-title":"Neuropathology of dementia in Parkinson's disease: A prospective, community-based study","volume":"58","author":"Aarsland","year":"2005","journal-title":"Ann Neurol"},{"key":"key20241101100449_b245-MI-4-6-00194","first-page":"S19","article-title":"Diagnostic imaging of degenerative diseases of the extrapyramidal system","volume":"106 (3 Suppl 1)","author":"Colosimo","year":"2003","journal-title":"Radiol Med"},{"key":"key20241101100449_b246-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol"},{"key":"key20241101100449_b247-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"key20241101100449_b248-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00314594","article-title":"Diffuse Lewy body disease in Japan","volume":"237","author":"Kosaka","year":"1990","journal-title":"J Neurol"},{"key":"key20241101100449_b249-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2990.1986.tb00136.x","article-title":"Idiopathic Parkinson's disease and the Lewy body disorders","volume":"12","author":"Gibb","year":"1986","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key20241101100449_b250-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"key20241101100449_b251-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00415-003-1029-9","article-title":"Autonomic dysfunctions in dementia with Lewy bodies","volume":"250","author":"Horimoto","year":"2003","journal-title":"J Neurol"},{"key":"key20241101100449_b252-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","article-title":"Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease","volume":"109","author":"Orimo","year":"2005","journal-title":"Acta Neuropathol"},{"key":"key20241101100449_b253-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s004150050572","article-title":"Autonomic failure preceding dementia with Lewy bodies","volume":"247","author":"Larner","year":"2000","journal-title":"J Neurol"},{"key":"key20241101100449_b254-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2010.08.056","article-title":"Relationship between orthostatic hypotension and cognitive impairment in the elderly","volume":"299","author":"Mehrabian","year":"2010","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b255-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/vhrm.s2434","article-title":"Risk factors for vascular dementia: Hypotension as a key point","volume":"4","author":"Moretti","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"key20241101100449_b256-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.27186","article-title":"Neuropathology of autonomic dysfunction in synucleinopathies","volume":"33","author":"Coon","year":"2018","journal-title":"Mov Disord"},{"key":"key20241101100449_b257-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamaneurol.2018.0640","article-title":"A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear Palsy","volume":"75","author":"De Pablo-Fernandez","year":"2018","journal-title":"JAMA Neurol"},{"key":"key20241101100449_b258-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","article-title":"Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease","volume":"310","author":"Sharabi","year":"2011","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b259-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10072-010-0239-z","article-title":"Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases","volume":"31","author":"Treglia","year":"2010","journal-title":"Neurol Sci"},{"key":"key20241101100449_b260-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1212\/wnl.52.6.1269","article-title":"Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases","volume":"52","author":"Iwanaga","year":"1999","journal-title":"Neurology"},{"key":"key20241101100449_b261-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1172\/JCI113298","article-title":"Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans","volume":"81","author":"Goldstein","year":"1988","journal-title":"J Clin Invest"},{"key":"key20241101100449_b262-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"key":"key20241101100449_b263-MI-4-6-00194","first-page":"1775","article-title":"Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure","volume":"46","author":"Tipre","year":"2005","journal-title":"J Nucl Med"},{"key":"key20241101100449_b264-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.parkreldis.2014.04.007","article-title":"Cardiovascular effects of levodopa in Parkinson's disease","volume":"20","author":"Noack","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b265-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","article-title":"Generation of circadian rhythms in the suprachiasmatic nucleus","volume":"19","author":"Hastings","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"key20241101100449_b266-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol"},{"key":"key20241101100449_b267-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov Disord"},{"key":"key20241101100449_b268-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0022-510x(95)00155-u","article-title":"Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis","volume":"132","author":"Kato","year":"1995","journal-title":"J Neurol Sci"},{"key":"key20241101100449_b269-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"e2051","DOI":"10.1212\/WNL.0000000000005641","article-title":"Disrupted hypothalamic functional connectivity in patients with Parkinson's disease and autonomic dysfunction","volume":"90","author":"Dayan","year":"2018","journal-title":"Neurology"},{"key":"key20241101100449_b270-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.parkreldis.2006.06.009","article-title":"Insular pathology in Parkinson's disease patients with orthostatic hypotension","volume":"13","author":"Papapetropoulos","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"129","key":"key20241101100449_b271-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0676-5","article-title":"Post-mortem assessment in vascular dementia: Advances and aspirations","volume":"14","author":"McAleese","year":"2016","journal-title":"BMC Med"},{"key":"key20241101100449_b272-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"key20241101100449_b273-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2018.12.004","article-title":"White matter in different regions evolves differently during progression to dementia","volume":"76","author":"Dadar","year":"2019","journal-title":"Neurobiol Aging"},{"key":"key20241101100449_b274-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1037\/\/0894-4105.14.2.224","article-title":"The cognitive correlates of white matter abnormalities in normal aging: A quantitative review","volume":"14","author":"Gunning-Dixon","year":"2000","journal-title":"Neuropsychology"},{"key":"key20241101100449_b275-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"key20241101100449_b276-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WAD.0b013e3181d71a13","article-title":"Influence of white matter hyperintensities on the cognition of patients with Parkinson disease","volume":"24","author":"Lee","year":"2010","journal-title":"Alzheimer Assoc Disord"},{"key":"key20241101100449_b277-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"e1803","DOI":"10.1212\/WNL.0000000000009316","article-title":"White matter hyperintensities mediate the association of nocturnal blood pressure with cognition","volume":"94","author":"Chesebro","year":"2020","journal-title":"Neurology"},{"key":"key20241101100449_b278-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1177\/0963689718795148","article-title":"Cerebral small vessel disease","volume":"27","author":"Li","year":"2018","journal-title":"Cell Transpl"},{"key":"key20241101100449_b279-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCRESAHA.118.313260","article-title":"Neurovascular and cognitive dysfunction in hypertension","volume":"124","author":"Iadecola","year":"2019","journal-title":"Circ Res"},{"key":"key20241101100449_b280-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/mdc3.13000","article-title":"White matter hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?","volume":"7","author":"Kaufmann","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"key20241101100449_b281-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/mdc3.12478","article-title":"Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension","volume":"4","author":"Palma","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"key20241101100449_b282-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/0003-4819-121-3-199408010-00004","article-title":"The anemia of primary autonomic failure and its reversal with recombinant erythropoietin","volume":"121","author":"Biaggioni","year":"1994","journal-title":"Ann Intern Med"},{"key":"key20241101100449_b283-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF01824009","article-title":"Effect of recombinant erythropoietin on anemia and Orthostatic Hypotension in primary autonomic failure","volume":"5","author":"Perera","year":"1995","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b284-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1152\/ajpregu.00544.2010","article-title":"The osmopressor response to water drinking","volume":"300","author":"May","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key20241101100449_b285-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","article-title":"Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"key20241101100449_b286-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Clinical practice. Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"N Engl J Med"},{"key":"key20241101100449_b287-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.parkreldis.2014.02.006","article-title":"Exercise hemodynamics in Parkinson's disease and autonomic dysfunction","volume":"20","author":"Low","year":"2014","journal-title":"Parkinson's disease Relat Disord"},{"key":"key20241101100449_b288-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/00004872-198900076-00017","article-title":"Relationship between splanchnic vasodilation and postprandial hypotension in patients with primary autonomic failure","volume":"(Suppl 7)","author":"Kooner","year":"1989","journal-title":"J Hypertens"},{"key":"key20241101100449_b289-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol"},{"key":"key20241101100449_b290-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"H1768","DOI":"10.1152\/ajpheart.00287.2006","article-title":"Leg crossing improves orthostatic tolerance in healthy subjects: A placebo-controlled crossover study","volume":"291","author":"Krediet","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20241101100449_b291-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.11124\/JBISRIR-D-18-00005","article-title":"Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly people and people with a neurological condition: A systematic review","volume":"18","author":"Logan","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"e28193","key":"key20241101100449_b292-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028193","article-title":"Are compression stockings an effective treatment for orthostatic presyncope?","volume":"6","author":"Protheroe","year":"2011","journal-title":"PLoS One"},{"key":"key20241101100449_b293-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.3233\/JPD-202036","article-title":"Management of Orthostatic Hypotension in Parkinson's Disease","volume":"10(S1)","author":"Fanciulli","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"key20241101100449_b294-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/NEJM197907123010202","article-title":"Mineralocorticoid-induced hypertension in patients with Orthostatic Hypotension","volume":"301","author":"Chobanian","year":"1979","journal-title":"N Engl J Med"},{"issue":"e006848","key":"key20241101100449_b295-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006848","article-title":"Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with Orthostatic Hypotension","volume":"6","author":"Grijalva","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key20241101100449_b296-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/jhh.2011.107","article-title":"Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome","volume":"27","author":"Norcliffe-Kaufmann","year":"2013","journal-title":"J Hum Hypertens"},{"key":"key20241101100449_b297-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2337\/diab.24.4.381","article-title":"9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy","volume":"24","author":"Campbell","year":"1975","journal-title":"Diabetes"},{"key":"key20241101100449_b298-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJM197911153012014","article-title":"Fludrocortisone in Orthostatic Hypotension","volume":"301","author":"Decaux","year":"1979","journal-title":"N Engl J Med"},{"key":"key20241101100449_b299-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02291388","article-title":"Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure","volume":"10","author":"Van Lieshout","year":"2000","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b300-MI-4-6-00194","first-page":"205","article-title":"The treatment of idiopathic Orthostatic Hypotension: A combined fludrocortisone and flurbiprofen regime","volume":"50","author":"Watt","year":"1981","journal-title":"Q J Med"},{"key":"key20241101100449_b301-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","article-title":"Management of neurogenic orthostatic hypotension: An update","volume":"7","author":"Low","year":"2008","journal-title":"Lancet Neurol"},{"key":"key20241101100449_b302-MI-4-6-00194","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"key20241101100449_b303-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/wnl.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"key20241101100449_b304-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","article-title":"Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs"},{"key":"key20241101100449_b305-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"key20241101100449_b306-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1007\/s10286-017-0431-9","article-title":"Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease","volume":"27 (Suppl 1)","author":"Goodman","year":"2017","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b307-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/s10286-017-0430-x","article-title":"Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension","volume":"27","author":"Gupta","year":"2017","journal-title":"Clin Auton Res"},{"key":"key20241101100449_b308-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/14656566.2018.1543404","article-title":"Chemical pharmacotherapy for the treatment of orthostatic hypotension","volume":"20","author":"Cheshire","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"key20241101100449_b309-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.111.184812","article-title":"Synergistic effect of norepinephrine transporter blockade and \u03b1-2 antagonism on blood pressure in autonomic failure","volume":"59","author":"Okamoto","year":"2012","journal-title":"Hypertension"},{"key":"key20241101100449_b310-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","article-title":"Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure","volume":"64","author":"Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"key20241101100449_b311-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.119.14483","article-title":"Predictors of the pressor response to the norepinephrine transporter inhibitor, atomoxetine. neurogenic orthostatic hypotension","volume":"78","author":"Shibao","year":"2021","journal-title":"Hypertension"},{"key":"key20241101100449_b312-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3988\/jcn.2017.13.1.15","article-title":"Cardiovascular autonomic dysfunction in patients with drug-induced parkinsonism","volume":"13","author":"Kim","year":"2017","journal-title":"J Clin Neurol"},{"key":"key20241101100449_b313-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer","year":"2006","journal-title":"Arch Neurol"},{"key":"key20241101100449_b314-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1212\/WNL.0000000000004340","article-title":"Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension","volume":"89","author":"Byun","year":"2017","journal-title":"Neurology"},{"key":"key20241101100449_b315-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00702-017-1791-y","article-title":"Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms","volume":"124","author":"Eschlb\u00f6ck","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"key20241101100449_b316-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pharmthera.2011.05.009","article-title":"Pharmacotherapy of autonomic failure","volume":"134","author":"Shibao","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key20241101100449_b317-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10072-012-1251-2","article-title":"Arterial hypertension, a tricky side of Parkinson's disease: Physiopathology and therapeutic features","volume":"34","author":"Mazza","year":"2013","journal-title":"Neurol Sci"},{"key":"key20241101100449_b318-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI118871","article-title":"Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells","volume":"98","author":"Zeng","year":"1996","journal-title":"J Clin Invest"},{"issue":"e018979","key":"key20241101100449_b319-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018979","article-title":"Local Passive Heat for the Treatment of Hypertension in Autonomic Failure","volume":"10","author":"Okamoto","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"key20241101100449_b320-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.122.20081","article-title":"Continuous positive airway pressure for the treatment of supine hypertension and orthostatic hypotension in autonomic failure","volume":"80","author":"Okamoto","year":"2023","journal-title":"Hypertension"},{"key":"key20241101100449_b321-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","article-title":"Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure","volume":"67","author":"Arnold","year":"2016","journal-title":"Hypertension"},{"key":"key20241101100449_b322-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","article-title":"Management of supine hypertension in patients with neurogenic orthostatic hypotension: Scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension","volume":"37","author":"Jordan","year":"2019","journal-title":"J Hypertens"},{"key":"key20241101100449_b323-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: Dementia with Lewy bodies and Parkinson disease dementia","volume":"22 (2 Dementia)","author":"Gomperts","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"key20241101100449_b324-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"key20241101100449_b325-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1177\/0269881198012003021","article-title":"Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology","volume":"12 (3 Suppl B)","author":"Goodnick","year":"1998","journal-title":"J Psychopharmacol"},{"key":"key20241101100449_b326-MI-4-6-00194","first-page":"1305","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"key20241101100449_b327-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2013.01.002","article-title":"Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study","volume":"64","author":"Wagg","year":"2013","journal-title":"Eur Urol"},{"key":"key20241101100449_b328-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/s0140-6736(82)92206-1","article-title":"Antiemetics: Neurotransmitter receptor binding predicts therapeutic actions","volume":"1","author":"Peroutka","year":"1982","journal-title":"Lancet"},{"key":"key20241101100449_b329-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/mdc3.12899","article-title":"Practical evaluation and management of insomnia in Parkinson's Disease: A review","volume":"7","author":"Wallace","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"CD011961","key":"key20241101100449_b330-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011961.pub2","article-title":"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's Disease","volume":"2","author":"Orgeta","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"e0193113","key":"key20241101100449_b331-MI-4-6-00194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193113","article-title":"Effects of physical exercise programs on cognitive function in Parkinson's Disease patients: A systematic review of randomized controlled trials of the last 10 years","volume":"13","author":"da Silva","year":"2018","journal-title":"PLoS One"},{"key":"key20241101100449_b332-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"25","DOI":"10.11138\/fneur\/2016.31.1.025","article-title":"Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's Disease: A pilot, single-blind, randomized controlled trial","volume":"31","author":"Picelli","year":"2016","journal-title":"Funct Neurol"},{"key":"key20241101100449_b333-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.07.006","article-title":"Transcranial magnetic stimulation improves cognition over time in Parkinson's Disease","volume":"66","author":"Trung","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"key20241101100449_b334-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2014.08.043","article-title":"Effects of tDCS on executive function in Parkinson's Disease","volume":"582","author":"Doruk","year":"2014","journal-title":"Neurosci Lett"},{"key":"key20241101100449_b335-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.brs.2018.07.046","article-title":"Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study","volume":"11","author":"Manenti","year":"2018","journal-title":"Brain Stimulat"},{"key":"key20241101100449_b336-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol"},{"key":"key20241101100449_b337-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's Disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin Interv Aging"},{"key":"key20241101100449_b338-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2013-306439","article-title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's Disease: A double-blind, placebo-controlled, randomised clinical trial","volume":"85","author":"Devos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b339-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1532-5415.1999.tb02576.x","article-title":"Orthostatic hypotension and cognitive decline in older people","volume":"47","author":"Viramo","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"key20241101100449_b340-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/gerona\/59.11.1191","article-title":"Effect of blood pressure on cognitive functions in elderly persons","volume":"59","author":"Kuo","year":"2004","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"key20241101100449_b341-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/mds.20996","article-title":"Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: Autonomic symptom and demographic comparison","volume":"21","author":"Allcock","year":"2006","journal-title":"Mov Disord"},{"key":"key20241101100449_b342-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000160955","article-title":"Orthostatic hypotension, hypotension and cognitive status: Early comorbid markers of primary dementia?","volume":"26","author":"Yap","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key20241101100449_b343-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.archger.2007.01.010","article-title":"Relation of neurocardiovascular instability to cognitive, emotional and functional domains","volume":"44 (Suppl 1)","author":"Bendini","year":"2007","journal-title":"Arch Gerontol Geriatr"},{"key":"key20241101100449_b344-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000255459","article-title":"Orthostatic hypotension and cognitive function: The Atherosclerosis Risk in Communities Study","volume":"34","author":"Rose","year":"2010","journal-title":"Neuroepidemiology"},{"key":"key20241101100449_b345-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WNF.0000000000000168","article-title":"Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension","volume":"39","author":"Hauser","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"key20241101100449_b346-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.5603\/KP.2018.0161","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"key20241101100449_b347-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.hyp.30.5.1062","article-title":"The hypertension of autonomic failure and its treatment","volume":"30","author":"Shannon","year":"1997","journal-title":"Hypertension"},{"key":"key20241101100449_b348-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","article-title":"Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure","volume":"61","author":"Arnold","year":"2013","journal-title":"Hypertension"},{"key":"key20241101100449_b349-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1681\/ASN.V10135","article-title":"Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure","volume":"10","author":"Jordan","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"key20241101100449_b350-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/mds.25098","article-title":"Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study","volume":"27","author":"Dubois","year":"2012","journal-title":"Mov Disord"},{"key":"key20241101100449_b351-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: Systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20241101100449_b352-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"key20241101100449_b353-MI-4-6-00194","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: A randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neuro"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:05:06Z","timestamp":1730448306000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2024.194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":353,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,9,19]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2024.194","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"article-number":"70"}}